Clinical Trial Update: Curcumin in Combination With 5FU for Colon Cancer [EARLY_Phase 1]

View source ↗

Summary

An early-phase (Phase 1) study evaluating the combination of curcumin and 5-fluorouracil in metastatic colorectal cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Curcumin (curcumin)

Snippet

Sponsor: Baylor Research Institute | Conditions: Metastatic Colon Cancer | EARLY_Phase 1 | Status: TERMINATED